MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkac412

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2023

Incidence and associated risk factors for systemic drug levels with inhaled aminoglycoside therapy.

Schultheis Jennifer M, Durham Mary E, Kram Shawn J, Kuhrt Michelle, Gilstrap Daniel L, Parish Alice, Green Cynthia L, Kram Bridgette L

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

OBJECTIVES

To characterize the incidence of and risk factors for a detectable drug level (DDL) in patients that received inhaled aminoglycoside therapy.

METHODS

This retrospective, single-centre study included adult patients who received at least one dose of an inhaled aminoglycoside with a drug level during inpatient hospitalization. Patients were excluded if they received an aminoglycoside intravenously within 7 days or if the drug level was not drawn within 4 h of the next dose. A repeated measures logistic regression model evaluated the association between potential risk factors and a DDL.

RESULTS

Among 286 drug levels, 88 (30.8%) drug levels were detectable. In multivariable analysis, cystic fibrosis (CF) (OR: 3.03; 95% CI: 1.10-8.35), chronic kidney disease (CKD) (OR: 4.25; 95% CI: 1.84-9.83), lung transplant recipient (OR: 3.08; 95% CI: 1.09-8.73), mechanical ventilation (OR: 2.99; 95% CI: 1.25-7.15) and tobramycin (OR: 5.26; 95% CI: 2.35-11.78) were associated with higher odds of a DDL. Among those with a DDL, inhaled aminoglycoside type and drug level concentration were not associated with acute kidney injury (P = 0.161).

CONCLUSIONS

Among 286 drug levels identified among inpatients receiving inhaled aminoglycoside therapy, 88 (30.8%) unique drug levels were detectable. Based on the results of this study, periodic trough concentrations should be considered for patients receiving inhaled aminoglycoside therapy with CF, CKD, lung transplantation, mechanical ventilation or tobramycin.

Для цитирования: Schultheis Jennifer M, Durham Mary E, Kram Shawn J, Kuhrt Michelle, Gilstrap Daniel L, Parish Alice, Green Cynthia L, Kram Bridgette L. Incidence and associated risk factors for systemic drug levels with inhaled aminoglycoside therapy.. The Journal of antimicrobial chemotherapy. 2023. DOI: 10.1093/jac/dkac412.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.